HDCRT Plus Pembrolizumab in Advanced Malignancies

Summary

This study is a pilot study to evaluate high-dose conformal radiation therapy (HDCRT) administered in combination with pembrolizumab in patients with solid tumors.

Timeline

Start

2017-03-21

Primary completion

2020-01-13

Completion

2020-02-10

Drugs

Indications